- Astra Zeneca
- Glaxo Wellcome
- SmithKlineBeecham
- Eli Lilly
- Novartis
- Roche
- Serono
- St. Jude Medical
Another (dubious) cost of doing business
Addressing threats to health care's core values, especially those stemming from concentration and abuse of power - and now larger threats to the democracy needed to advance health and welfare. Advocating for accountability, integrity, transparency, honesty and ethics in leadership and governance of health care.
Pages
▼
Friday, October 28, 2005
Pharmaceutical and Device Companies Involved in Oil-for-Food Scandal
Now that the Volcker report is out about how more than 2000 companies paid bribes to Saddam Hussein's regime in Iraq in order to sell products under the United Nation's oil for food program, it's no surprise that a number of prominent pharmaceutical and medical device companies were involved. So far, these include:
Another (dubious) cost of doing business
Another (dubious) cost of doing business
Thanks for this update.
ReplyDeleteI knew about the Swiss companies but not the others.
Looking at the kickbacks (sorry - "after sales service") it looks like around 10% of sales was the going rate.
The usual game would be that the negotiating pharma exec would also get a "reverse-kickback" of 10% of the 10% given to the Iraqi (this would make them dirty as well and reduce future whistleblowing opportunities).